MarketFriction

Star Health & Allied Insurance Company Ltd

NSE STARHEALTH · BSE 543412 · General Insurance
₹537.70 +0.57%
NSE close2026-10-01
52 week range416.55 - 624.90
Market cap₹31,674 Cr.
P/E37.5
IPO 2021 · -40% since Results 27-10 Nifty 500Smallcap 250 Price band 20% Delivery 69.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3,4613,5783,6883,8164,0584,1464,0814,8804,3784,5664,6485,522
Expenses3,2963,1913,5023,3913,9123,8614,0894,2924,3034,3954,5004,773
Operating Profit165387186425147285-758875172148749
OPM %4.8%11%5%11%3.6%7%-0.2%12%1.7%3.8%3.2%14%
Other Income2131226-0324-8
Interest000000000000
Depreciation000000000000
Profit before tax167388190426149287-158878173151742
Tax %25%25%25%25%25%25%-159%25%29%26%26%26%
Net Profit125290142319111215143855128111550
EPS in Rs2.154.952.435.451.893.660.017.450.932.181.899.34
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,5952,0122,8883,7754,9875,05010,60212,09614,02116,10117,82519,114
Expenses1,4391,8712,6733,5654,5446,44711,96211,22312,84015,18017,00117,971
Operating Profit156141215210443-1,397-1,3608731,1829218241,143
OPM %10%7%7%6%9%-28%-13%7%8%6%4.6%6%
Other Income00000-37561291
Interest2320000000000
Depreciation18202328294643525971790
Profit before tax137118171182413-1,446-1,3978261,1298617541,144
Tax %0%0%1%30%35%-25%-25%25%25%25%26%
Net Profit137118170128268-1,086-1,041619845646557844
EPS in Rs3.532.593.732.815.46-19.81-18.0810.6314.4410.999.4714.34
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth27%29%14%11%
Compounded Profit Growth15%20%-3%10%
Stock Price CAGR%%-4%20%
Return on Equity3%6%10%8%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital362387456456456491548576582585588588
Reserves-220-273345047731,1532,9474,0454,8625,7996,4716,987
Borrowings000250250250250720470470470470
Other Liabilities9541,0121,4232,1383,3944,2336,7568,1749,31310,91413,25516,019
Total Liabilities1,0961,3722,2133,3474,8726,12710,50113,51415,22617,76820,78524,064
Fixed Assets466277928590183113217159357404
CWIP1237513121941016249
Investments5028071,4282,1653,0304,2906,73311,37313,27615,49117,70319,780
Other Assets5355007001,0851,7441,7353,5652,0241,7232,1022,7013,871
Total Assets1,0961,3722,2133,3474,8726,12710,50113,51415,22617,76820,78524,064
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity321557776647890561,2761,3101,3791,873
Cash from Investing Activity-497-663-731-1,006-2,418-3,786-1,097-1,177-1,151-1,067
Cash from Financing Activity3102493331222,6132,509-26823-4-31
Net Cash Flow134143379-2371,086-1,221-89156224775
Free Cash Flow283521746614844-71,2291,1871,2971,797
CFO/OP228%260%397%168%-70%-4%145%119%170%250%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days000000000000
Inventory Days
Days Payable
Cash Conversion Cycle000000000000
Working Capital Days-255-179-191-196-260-238-397-258-255-249-261-286
ROCE %55%21%19%14%25%-51%-31%15%18%12%10%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters58.01%57.94%57.92%57.90%57.70%57.68%57.67%58.04%58.03%57.98%57.98%58.01%
FIIs30.63%31.01%26.57%21.58%17.65%17.51%18.69%13.89%13.51%14.07%15.06%16.04%
DIIs6.11%6.11%11.14%15.10%17.05%16.49%15.44%21.08%21.09%20.96%20.31%19.41%
Public5.23%4.96%4.38%5.40%7.60%8.32%8.22%6.97%7.38%6.99%6.66%6.55%
No. of Shareholders1,71,4231,83,3431,75,2981,89,3471,96,7782,17,5162,21,6122,03,5632,02,9381,86,4481,79,0671,68,763

Fundamentals

Market Cap₹ 31,674 Cr.
Current Price₹ 538
Stock P/E37.5
Book Value₹ 129
ROCE9.69 %
ROE7.61 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)11%
Compounded Profit Growth (TTM)10%
Standalone figures.
Valuation
Market capRs 31,638 Cr
Enterprise valueRs 30,665 Cr
P/E (TTM)37.48x
Price to book4.18x
Price to sales1.66x
EV / EBITDA25.07x
EV / EBIT26.80x
EV / sales1.60x
Price to cash flow16.89x
Earnings yield2.67%
P/E, 3-year average39.48x
P/B, 3-year average3.84x
P/E, 5-year average41.79x
P/B, 5-year average5.18x
Profitability
Operating margin (excl. other income)4.62%
Operating margin (incl. other income)4.68%
EBITDA margin6.40%
Pre-tax margin5.99%
Net profit margin4.42%
Net margin, latest quarter9.96%
ROE7.61%
ROCE9.69%
ROA2.48%
ROE, 3-year average10.50%
ROCE, 3-year average13.11%
ROA, 3-year average3.65%
ROE, 5-year average3.63%
ROCE, 5-year average4.66%
ROA, 5-year average1.32%
ROIC (approx.)12.80%
Tax rate26.16%
Other income / net worth0.12%
Growth
Sales growth (latest year)10.71%
Profit growth (latest year)-13.76%
Sales CAGR, 3 years13.80%
Sales CAGR, 5 years28.69%
Profit CAGR, 3 years-3.44%
Sales growth QoQ18.80%
Profit growth QoQ393.74%
Sales growth YoY (latest quarter)13.15%
Profit growth YoY (latest quarter)25.46%
Per share
EPS (TTM)Rs 14.35
EPS (latest year)Rs 9.47
EPS (latest quarter)Rs 9.34
EPS, 3-year averageRs 11.63
EPS, 5-year averageRs 5.49
Book value per shareRs 128.74
Sales per shareRs 324.85
Cash flow per shareRs 31.84
Free cash flow per shareRs 30.54
Efficiency
Asset turnover0.74x
Fixed asset turnover44.08x
Cash conversion cycle0 days
Working capital days-286 days
Leverage
Total debtRs 470 Cr
Cash and bankRs 1,444 Cr
Net debtRs -974 Cr
Debt to equity0.06x
Net debt / EBITDA-0.80x
Owners' fund to total sources31.48%
Debt to assets1.95%
Cash flow
Cash from Operating Activity (latest year)Rs 1,873 Cr
Cash from Investing Activity (latest year)Rs -1,067 Cr
Cash from Financing Activity (latest year)Rs -31 Cr
Net Cash Flow (latest year)Rs 775 Cr
Free cash flow (latest year)Rs 1,797 Cr
FCFE (approx.: FCF + change in debt)Rs 1,797 Cr
Cash from ops / profit, 5 years3.62x
Sales to cash flow9.51x
Statement figures
Net sales (TTM)Rs 19,114 Cr
Net sales (latest year)Rs 17,825 Cr
Sales (latest quarter)Rs 5,522 Cr
Operating profit excl. other income (latest year)Rs 824 Cr
Operating profit (latest quarter)Rs 749 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 1,223 Cr
PBDT (TTM)Rs 1,223 Cr
Profit before tax (TTM)Rs 1,144 Cr
Tax (latest year)Rs 197 Cr
Net profit (TTM)Rs 844 Cr
Net profit (latest year)Rs 557 Cr
Net profit (latest quarter)Rs 550 Cr
Depreciation (TTM)Rs 79 Cr
Cost of goods sold (latest year)Rs 14,048 Cr
Total expenditure (latest year)Rs 17,001 Cr
Total income (latest year)Rs 17,834 Cr
Share capitalRs 588 Cr
ReservesRs 6,987 Cr
Shareholders' fundsRs 7,575 Cr
Total assetsRs 24,064 Cr
Net blockRs 404 Cr
Capital work in progressRs 9 Cr
InvestmentsRs 19,780 Cr
Other liabilitiesRs 16,019 Cr
Shares outstanding (crore)58.84
Ownership
Promoter holding58.01% (-0.03 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 37.5 is at the 24th percentile of its own 3.4-year range (median 42.3, low 26.6, high 60.5).
P/B 4.18 is at the 25th percentile (median 5.78).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodSTARHEALTHNifty 50Difference
1 week-2.3%-2.8% +0.5 pts
1 month-4.1%-6.8% +2.7 pts
3 months-7.3%-7.6% +0.3 pts
6 months+17.5%+0.4% +17.1 pts
1 year+17.9%-9.9% +27.9 pts
2 years-11.8%-13.6% +1.7 pts
3 years-10.5%+14.2% -24.7 pts
69 mutual fund schemes hold about ₹3,841 Cr. Over three months 9 bought more and 13 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
HDFC Mid Cap Fund1.08%1,170 -3%
SBI Small Cap Fund1.29%551 -2%
SBI Midcap Fund1.46%359 +2%
SBI Midcap Fund1.46%356 +2%
SBI Banking & Financial Services Fund1.74%189 +4%
HDFC ELSS-Tax Saver Fund1.06%170 +2%
Nippon India Banking & Financial Services Fund2.02%160 +9%
Nippon India Balanced Advantage Fund0.87%86 -9%
Tata Banking & Financial Services Fund2.21%73 -0%
Bandhan Small Cap Fund0.20%68 -13%
JM Flexi Cap Fund1.30%67 +2%
ICICI Pru Banking & Fin Serv Fund0.48%54 -8%
ICICI Pru Banking & Fin Serv Fund0.48%54 -8%
Aditya Birla SL Multi Asset Allocation Fund0.60%46 -5%
Abakkus Small Cap Fund1.54%43 -5%
HDFC Retirement Fund-Equity Plan0.61%43 +2%
Tata Multi Asset Allocation Fund0.70%37 +100%
Aditya Birla SL Banking & Financial Services Fund0.96%35 +4%
Quantum Value Fund3.04%34 -11%
HDFC Large & Mid Cap Fund0.11%34 +1%
Nippon India Value Fund0.25%23 +100%
Nippon India Nifty Smallcap 250 Index Fund0.60%21 +0%
HDFC Dividend Yield Fund0.29%16 +5%
Axis ESG Integration Strategy Fund1.35%15 +4%
HDFC Multi Asset Allocation Fund0.23%14 +1%

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2025-06-03SETU AIF TRUSTPromoter Groupbuy176,997Rs 8.39 CrMarket Purchase
2025-06-02SETU AIF TRUSTPromoter Groupbuy67,000Rs 3.18 CrMarket Purchase
2025-06-02SETU AIF TRUSTPromoter Groupbuy290,121Rs 13.76 CrMarket Purchase
2025-05-30SETU AIF TRUSTPromoter Groupbuy281,873Rs 13.44 CrMarket Purchase
2025-05-30SETU AIF TRUSTPromoter Groupbuy70,043Rs 3.34 CrMarket Purchase
2025-05-29SETU AIF TRUSTPromoter Groupbuy270,538Rs 12.95 CrMarket Purchase
2025-05-29SETU AIF TRUSTPromoter Groupbuy23,000Rs 1.09 CrMarket Purchase
2025-05-28SETU AIF TRUSTPromoter Groupbuy285,534Rs 13.50 CrMarket Purchase
2025-05-28SETU AIF TRUSTPromoter Groupbuy103,000Rs 4.89 CrMarket Purchase
2025-05-27SETU AIF TRUSTPromoter Groupbuy231,539Rs 10.73 CrMarket Purchase
2022-12-29Nilesh KambliEmployees/Designated Employeother237,000Rs 13.64 CrPledge Creation
2022-12-27VASANTHI JAGANNATHANImmediate relativebuy72,500Rs 4.17 CrMarket Purchase
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹5,522 Cr +13.2% vs Jun 2025. Net profit ₹550 Cr +25.6%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
ICICI Lombard General Insurance Company Ltd75,69231.221.9 %
General Insurance Corporation of India56,1856.3317.4 %
New India Assurance Company Ltd27,73436.04.29 %
Go Digit General Insurance Ltd23,41147.513.1 %
Niva Bupa Health Insurance Company Ltd13,55177.83.15 %
No bulk or block deals on record.
No corporate actions on record.
DateTypeWhat it says
2026-10-01Credit RatingCredit Rating
2026-09-30General UpdatesReceipt of request for reclassification of promoter group entity to the public category.
2026-09-22Concall / analyst meetSchedule of meet with Analysts/Investors dated September 29, 2026.
2026-09-22Concall / analyst meetSchedule of meet with Analysts/Investors dated September 28, 2026.
2026-09-17General UpdatesDisclosure under Regulation 31A(8)(C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-09-17Concall / analyst meetSchedule of meet with Analyst/Investors dated September 23, 2026.
2026-09-17Concall / analyst meetSchedule of meet with Analyst/Investors dated September 22, 2026.
2026-09-16General UpdatesApproval of Board of Directors for withdrawal of application of reclassification of shareholders from "Promoter/Promoter Group" category to "Public" c...
2026-09-15Concall / analyst meetSchedule of group meet with Analysts/Investors dated September 21, 2026.
2026-09-15Concall / analyst meetSchedule of one-to-one meet with Analysts/Investors dated September 21, 2026
2026-09-11General UpdatesDisclosure under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
2026-09-11Concall / analyst meetSchedule of group meet with Analysts/Investors dated September 18, 2026
2026-09-11Concall / analyst meetSchedule of one to one meets with Analysts/Investors dated September 18, 2026.
2026-09-11Concall / analyst meetSchedule of meet with Analyst/Investor dated September 16, 2026.
2026-09-11Concall / analyst meetSchedule of virtual meet with Analyst/Investors dated September 16, 2026.
2026-08-29Shareholder meetingVoting results of Annual General Meeting held on August 28, 2026
2026-08-29Shareholder meetingStar Health and Allied Insurance Company Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 28, 20...
2026-08-28AppointmentAppointment of Mr. Utpal Hemendra Sheth as Non- Executive Nominee Director of the company w.e.f. August 28, 2026.
2026-08-28Shareholder meetingProceedings of 21st Annual General Meeting held on August 28, 2026
2026-08-28Concall / analyst meetSchedule of meet with Analyst/Investor dated September 02, 2026
2026-08-27Concall / analyst meetSchedule of meet with Analyst/Investor dated September 01, 2026
2026-08-26General UpdatesThe disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
2026-08-14UpdatesDisclosure under Regulation 31A(8)(C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
2026-08-13Concall / analyst meetSchedule of meet with Analyst/Investor dated August 25, 2026.
2026-08-13Concall / analyst meetSchedule of meet with Analyst/Investor dated August 20, 2026.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Star Health & Allied Insurance Company Ltd?

Star Health & Allied Insurance Company Ltd (STARHEALTH) has a market capitalisation of Rs 31,674 Cr. at the 2026-10-01 close.

What is the P/E ratio of Star Health & Allied Insurance Company Ltd?

Star Health & Allied Insurance Company Ltd trades at a P/E of 37.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were Star Health & Allied Insurance Company Ltd's latest quarterly results?

In the Jun 2026 quarter, Star Health & Allied Insurance Company Ltd sales was Rs 5,522 Cr (+13.2% vs Jun 2025) and net profit was Rs 550 Cr.

What is the 52-week high and low of Star Health & Allied Insurance Company Ltd?

The 52-week high is Rs 624.90 and the 52-week low is Rs 416.55.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03